CDMO Services for Development and Validation of a Colorectal Cancer Screening Immunoassay
Awarded
The competition has ended and a winner has been selected.
- Deadline
- 8. juniExpired
- Award
- Quality, weight 80
Brief
Trinity College Dublin the University of Dublin_336 has entered into an agreement with Fleet Bioprocessing for CDMO services for the development and validation of a colorectal cancer screening immunoassay. The services, valued at 115,000 EUR, will be delivered over 18 months and include assay optimisation, development of protocols for clinical and analytical validation, design control documentation, and manufacturing development services. The buyer required an ISO 13485 2016 accredited Contract Development and Manufacturing Organisation (CDMO).
Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester
Result
- Fleet BioprocessingWinner
- 2Number of tenders received
- €115,000Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Trinity College Dublin the University of Dublin_336
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Cost @ 20%
Source
No source found in the documents. Check the weight against the tender documents.
Description
Quality @ 80%
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Trinity College Dublin seeks to appoint an ISO 13485 2016 accredited Contract Development and Manufacturing Organisation CDMO to provide comprehensive assay optimisation, develop protocols for clinical and analytical validation, design control documentation and manufacturing development services for a proprietary colorectal cancer CRC screening immunoassay.
Contact
mireilly@tcd.ie- ResultType
- DublinLocation
- 73100000Main codeResearch and experimental development services